Literature DB >> 34923228

Voiding and storage symptoms in depression/anxiety.

Ryuji Sakakibara1, Shuichi Katsuragawa2.   

Abstract

We here described the frequency and nature of voiding and storage bladder symptoms in depression/anxiety, for which we propose the name "bladder somatic symptom disorder (SSD)" because such symptoms most probably have brain mechanisms. SSD was formerly called as various terms including "somatoform disorder", "medically unexplained physical symptoms", "functional somatic syndrome" and "hysterical neurosis/hysteria". Bladder SSD has the following specific features that are distinguishable from "true" neurologic/organic bladder dysfunction: 1) situation-dependence (close association with life event in some), 2) urodynamically increased bladder sensation/hypersensitivity and 3) absence of neurologic/organic diseases, in addition to 4) other stress symptoms (insomnia, etc.), are key clues to the possibility of bladder SSD. Urodynamics in these patients showed, to a lesser extent, underactive bladder without post-void residual. These findings might reflect the biological changes of the depressive brain; e.g., decreases in serotonin and GABA, and possible increases in CRH. Treatment of bladder SSD can follow that of general depression/anxiety, with the potential addition of anticholinergic or selective beta3 bladder drugs.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anxiety; Depression; Hypersensitivity; Increased bladder sensation; Psychogenic urinary dysfunction

Mesh:

Year:  2021        PMID: 34923228     DOI: 10.1016/j.autneu.2021.102927

Source DB:  PubMed          Journal:  Auton Neurosci        ISSN: 1566-0702            Impact factor:   3.145


  2 in total

1.  Urodynamically proven lower urinary tract dysfunction in children after COVID-19: A case series.

Authors:  Ismail Selvi; Muhammet İrfan Dönmez; Orhan Ziylan; Tayfun Oktar
Journal:  Low Urin Tract Symptoms       Date:  2022-03-15       Impact factor: 1.374

2.  Valerian essential oil for treating insomnia via the serotonergic synapse pathway.

Authors:  Wenfei Wang; Yichun Wang; Qiuting Guo; Huiting Li; Zhaoqiang Wang; Jia Li; Taotao Li; Tiantian Tang; Yujiao Wang; Yanzhuo Jia; Yao Wang; Junbo Zou; Yajun Shi; Dongyan Guo; Ming Yang; Xiaofei Zhang; Jing Sun
Journal:  Front Nutr       Date:  2022-07-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.